Haemato-Oncology Group & Centre for In Vivo Modelling
The central aim of Professor Kamil Kranc's group is to discover the key mechanisms regulating leukaemic stem cell (LSC) biology and harness this knowledge to selectively eradicate LSCs, thus pioneereing novel and efficient leukaemia therapies.